title: In reference to Fu et al. (neuro-Oncology 2008:10139-152).
authors.forename: Rafael
authors.initials: R
authors.lastname: Roesler
authors.forename: Nadja
authors.initials: N
authors.lastname: Schröder
authors.forename: Gilberto
authors.initials: G
authors.lastname: Schwartsmann
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy*; D006801:Humans; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D011719:Pyrazines / Q000627:therapeutic use*; D016194:Receptors, N-Methyl-D-Aspartate / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D011719:Pyrazines; D016194:Receptors, N-Methyl-D-Aspartate; C017953:tetramethylpyrazine